Cubist Systematic Strategies »

Prelude Therapeutics shares owned by Cubist Systematic Strategies

Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Cubist Systematic Strategies from 13F filings

Historical chart of Cubist Systematic Strategies investment in Prelude Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Prelude Therapeutics held by Cubist Systematic Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prelude Therapeutics by Cubist Systematic Strategies

Quarter filed Position value Share count Share price at filing
2024-09-30 $83k 40k 2.07
2023-03-31 $50k 8.8k 5.70
2022-06-30 $208k 40k 5.21
2021-12-31 $1.4M 116k 12.45
2021-09-30 $680k 22k 31.26
2021-06-30 $492k 17k 28.61
2021-03-31 $277k 6.4k 43.32
2020-09-30 $3.0k 100 30.00

More positions owned by Cubist Systematic Strategies

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation (NVDA)
Netflix (NFLX)
Microsoft Corporation (MSFT)
Super Micro Computer Call Option (SMCI)
General Motors Company (GM)
Spotify Technology S A SHS (SPOT)
Meta Platforms Cl A (META)
Micron Technology Call Option (MU)
Arm Holdings Sponsored Ads Call Option (ARM)
Intel Corporation Call Option (INTC)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Snowflake Cl A (SNOW)
Tesla Motors Call Option (TSLA)

View all positions for Cubist Systematic Strategies

Top funds holding Prelude Therapeutics

OrbiMed Advisors
Baker Bros. Advisors
Deerfield Management Company
Boxer Capital
T. Rowe Price Associates
BlackRock
BlackRock
Vanguard Group
ExodusPoint Capital Management
Avidity Partners Management
Massachusetts Financial Services
Geode Capital Management
Marshall Wace
Sio Capital Management
Morgan Stanley

View all funds holding Prelude Therapeutics